MedPath
TGA Approval

REYATAZ atazanavir 200mg capsule bottle (99056)

99056

REYATAZ atazanavir 200mg capsule bottle

Bristol-Myers Squibb Australia Pty Ltd

January 12, 2004

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/2a574ec5d2e0c3e2bb4015686a19398e.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/975facaff3deb868a23757ab28497445.pdf

Active Ingredients

atazanavir sulfate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

REYATAZ atazanavir 200mg capsule bottle (99056) - TGA 批准文号 | MedPath